Denali Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Denali Therapeutics by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $6.2M | 291k | 21.46 |
2023-09-30 | $2.3M | 110k | 20.63 |
2023-06-30 | $3.9M | 132k | 29.51 |
2023-03-31 | $2.9M | 127k | 23.04 |
2022-12-31 | $3.3M | 120k | 27.81 |
2022-09-30 | $1.3M | 43k | 30.68 |
2022-06-30 | $189k | 6.4k | 29.61 |
2022-03-31 | $1.3M | 39k | 32.24 |
2021-12-31 | $4.1M | 92k | 44.63 |
2021-09-30 | $3.3M | 65k | 50.42 |
2021-06-30 | $191k | 2.4k | 78.38 |
2021-03-31 | $1.7M | 30k | 57.11 |
2020-12-31 | $485k | 5.8k | 83.68 |
2020-09-30 | $224k | 6.3k | 35.86 |
2020-06-30 | $65k | 2.7k | 24.29 |
2020-03-31 | $207k | 12k | 17.53 |
2019-12-31 | $41k | 2.3k | 17.86 |
2019-09-30 | $73k | 4.7k | 15.33 |
2019-06-30 | $89k | 4.3k | 20.85 |
2019-03-31 | $93k | 4.0k | 23.25 |
2018-12-31 | $1.6M | 79k | 20.69 |
2018-09-30 | $196k | 9.1k | 21.59 |
2018-06-30 | $139k | 9.0k | 15.39 |
2018-03-31 | $215k | 11k | 19.66 |
2017-12-31 | $3.0k | 200 | 15.00 |